| ASSET | QUARTER | % RETURN |
|---|---|---|
QXO (QXO) | Q2 2012 | 157,100% |
Intellinetics (INLX) | Q1 2012 | 42,600% |
OLB (OLB) | Q2 2012 | 7,964.52% |
Par Pacific (PARR) | Q3 2012 | 1,650% |
Protagenic Therapeutics (PTIX) | Q1 2012 | 1,214.63% |
Supercom (SPCB) | Q4 2012 | 1,066.67% |
BOS Better Online Solutions (BOSC) | Q4 2012 | 912.8% |
Vivakor (VIVK) | Q2 2012 | 842.42% |
QXO (QXO) | Q1 2012 | 800% |
FlexShopper (FPAY) | Q2 2012 | 750% |
Cocrystal Pharma (COCP) | Q4 2012 | 537.25% |
Netcapital (NCPL) | Q3 2012 | 533.33% |
Recon Technology (RCON) | Q1 2012 | 531.48% |
Coda Octopus (CODA) | Q1 2012 | 500% |
OptimumBank (OPHC) | Q1 2012 | 450.09% |
Arena (AREN) | Q2 2012 | 448.38% |
Sellas Life Sciences (SLS) | Q1 2012 | 372.34% |
Avita Medical (RCEL) | Q2 2012 | 369.77% |
TOMI Environmental Solutions (TOMZ) | Q3 2012 | 354.55% |
Sarepta Therapeutics (SRPT) | Q3 2012 | 321.21% |
Supercom (SPCB) | Q2 2012 | 275% |
Astrana Health (ASTH) | Q3 2012 | 275% |
Optex Systems Holdings, Inc Common Stock (OPXS) | Q1 2012 | 271.43% |
Intrusion (INTZ) | Q3 2012 | 253.1% |
Netcapital (NCPL) | Q1 2012 | 250% |
